Skip to main content
TC

The Cat Health

This company develops evidence-based longevity medicines specifically for cats by addressing the molecular mechanisms of aging. Utilizing computational modeling and machine learning, they design therapeutics aimed at delaying disease onset and extending healthy lifespan. Their goal is to improve the quality of life for senior cats by treating the biology of aging itself.

Bristol, United KingdomFounded 20244200+ followers
Updated 20 months ago

Funding

$540K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

EG
Funding rounds are not available yet.

Founders

Product

Problem

The health and lifespan of domestic cats are often compromised by age-related diseases and a lack of personalized preventative care. Current veterinary practices often lack the data-driven insights needed for early detection and targeted interventions to improve feline well-being.

Solution

Cat Health Data Science C-Corp collects and analyzes omics data from feline cohorts to identify biomarkers and health indicators associated with aging and disease. By applying advanced data analytics and machine learning techniques to this rich dataset, the company aims to develop personalized health solutions that extend the lifespan and improve the quality of life for cats. The company's research-driven approach seeks to provide actionable insights for veterinarians and cat owners, enabling targeted interventions and better preventative care strategies. The ultimate goal is to translate omics data into practical tools and therapies that address the specific health challenges faced by aging felines.

Target Audience

The primary target audience includes veterinarians, feline health researchers, and cat owners seeking data-driven insights to improve the health and longevity of their cats.

Features

  • Collection of omics data (e.g., genomics, proteomics, metabolomics) from feline cohorts.
  • Identification of biomarkers associated with age-related diseases in cats.
  • Development of machine learning models to predict health risks and personalize interventions.
  • Collaboration with EpiPaws to fund and manage data collection efforts.
This profile is AI-generated and may contain inaccuracies.